Renomedullary interstitial cells (RMIC) are unique to the renal medulla. By virtue of their anatomic location and arrangement, RMIC may hinder axial dissipation of the concentration gradient, thereby aiding urinary concentration. A more active role in urinary concentration has been postulated on the basis of speculations about RMIC contractile potential, however, RMIC contraction has not been investigated. To determine if these cells are contractile, cultured rat RMIC were exposed to endothelin-1 (ET-1), a potent vasoconstrictor which binds to RMIC, and examined using video microscopy. ET-1 (as low as 10 pM) caused a slowly developing and dose-dependent reduction in RMIC surface area. ET-1 markedly increased the number and intensity of F-actin microfilament staining. ET-1-induced RMIC contraction was not altered by nifedipine, was partially reduced by nickel, and was completely inhibited by H7, indicating that ET-1 action is mediated by protein kinase C and is partially dependent upon receptor-operated calcium channels. The ET-1 effect does not involve nitric oxide since NGmonomethyl-L-argiinine did not alter ET-1-induced RMIC contraction; in addition, ET-1 had only a minor effect on cGMP levels and no effect on nitrite production. PGE2 acts in an autocrine manner to dampen ET action since indomethacin potentiates, while PGE2 inhibits, ET-1-induced RMIC contraction. The contractile response is not unique to ET-1 since vasopressin also reduces RMIC surface area and increases F-actin microfiliment staining. These studies demonstrate that RMIC in culture are contractile. The possibility is raised that contraction of RMIC plays a role in modifying urinary concentration as well as regulation of other renal medullary functions. (J. Clin. Invest. 1995. 96:411-416.)
Introduction
Renomedullary interstitial cells (RMIC)1 are stellate cells that are unique to the renal medulla and are most prevalent towards the papillary tip (1, 2) . They are perhaps best known for their ability to synthesize large quantities of vasodepressor lipids or lipid precursors, including PGE2 and medullipin I (3, 4) . Release of these lipids by RMIC has been postulated to play a role in regulating blood pressure and the development of hypertension (5) . RMIC may also be involved in regulating urine concentration, however such a role for these cells has not been well studied. RMIC typically bridge the interstitium between medullary blood vessels and thin limbs of Henle's loops, forming a ladder-like arrangement with the long axis of the cells perpendicular to the long axis of the papilla (6) . This anatomic arrangement suggests a number of functions that RMIC may play in maintaining urinary concentrating ability. Most apparently, they could provide structural support for the medulla and papilla. In addition, because of their orientation, RMIC are likely to hinder axial diffusion in the medulla (6) , thereby limiting dissipation of the solute concentration gradient. In regards to this latter point, it is interesting to note that the kangaroo rat, a desert rodent with the ability to concentrate urine to an unusually high degree, has the greatest abundance of papillary RMIC known (7) . A third possible function for RMIC has been postulated: contraction. These cells have cytoplasmic myoid fibrils (8) and, as mentioned above, are anchored to adjacent blood vessels and Henle's loops. In 1956, Sternberg and coworkers noted that "should these cells (RMIC) prove to have a contractile function, they might play a role in the regulation of urinary volume," (7) . In 1990, Fontoura et al. described atrial natriuretic factor (ANF) receptors on RMIC and noted that the contractile state of RMIC may influence flow, pressure, or passive permeability characteristics of the vasa recta or Henle's loops (9) . To date, however, a contractile ability of RMIC has not been reported. The purpose of the current study was, therefore, to determine if RMIC were contractile.
A number of vasoactive mediators have been demonstrated to bind to, and activate signal transduction systems in, RMIC. These include atrial natriuretic factor (9), nitric oxide (10), angiotensin I (4, 11) , bradykinin (4), vasopressin (4, 12) , and endothelin-1 (ET-1 ) (13) . Because of ongoing research interest by this laboratory in the production and actions of ET-1 in the renal medulla (14-16), we chose to examine the effect of this peptide on RMIC contraction. ET-1 is a 21-amino acid peptide that is the most potent vasoconstrictor known (17) . It binds to high affinity receptors on RMIC and elicits an increase in cytosolic-free Ca2+ concentration that is dependent in part upon increases in inositol trisphosphate levels and receptor-operated Ca2+ channels (13) . We report that ET-1 causes a long-lasting and potent contraction of cultured rat RMIC. In addition, the mechanism of ET-1-induced RMIC contraction is explored.
Finally, the effect of arginine vasopressin (AVP) on RMIC contraction is examined to determine if the response is unique to ET-1. min. Changes in surface area were assessed over the duration of the incubation. Varying concentrations of ET-1 or 10 nM AVP were added immediately after the coverslips were placed in the incubation chamber and baseline cell surface area recorded. Cell surface area was then recorded for 30-60 min in the presence of ET-1 or AVP. For studies on the effects of nifedipine, nickel, NMMA, indomethacin, and 1-(5-isoquinoline sulfonyl)-2-methylpiperazine dihydrochloride (H7) on ET-1-induced contractions two protocols were followed. In the first, the effects of these reagents alone on cell surface area was determined in a manner identical to that for ET-1 above. In the second, the effects of these reagents on ET-1 actions was assessed by preincubating the cells for 30 min with the above reagents. The cells were then placed in the incubation chamber, ET-1 added in the continued presence of the various compounds, and changes in surface area assessed for 30 min as described above. Finally, for studies with PGE2-, PGE2 and ET-1 were added at the same time to cells that had been preincubated in indomethacin.
Methods
Staining of F-actin microfilaments. RMIC were stained using previously described methodology (19) . Briefly, cells were incubated in KRB alone or containing 10 nM ET-1 or 10 nM AVP for 30 min at 37°C. Coverslips were then rinsed in PBS, fixed with 3.7% formaldehyde in PBS for 10 min at 23°C, rinsed, permeabilized with 0.2% Triton X-100 in PBS for 1 min at 23°C, and rinsed again. Cells were then incubated with 5.0 U/ml rhodamine-phalloidin in PBS for 30 min in the dark on a rotary shaker, rinsed, and mounted using 1:1 PBS/glycerol, and photographed using a microscope (Carl Zeiss, Inc., Thornwood, NY) equipped with a mercury lamp, epifluorescence illumination, and a camera (Polaroid Corp., Cambridge, MA). All photomicrographs were obtained under identical conditions. Determination of cyclic nucleotide accumulation. RvMIC in 24-well plates were preincubated with 0.1 mM 3-isobutyl-I-methylxanthine for 30 min in KRB followed by addition of varying concentrations of ET-1 for 5-10 min at 370C. The media was then removed and the cells treated with 100% ethanol overnight. The ethanol was subsequently evaporated, the samples resuspended in assay buffer and cGMP, and cAMP determined using commercially available radioimmunoassay kits (Amersham Corp., Arlington Heights, IL). The remaining cell protein was solubilized in 0.1 N NaOH, an aliquot mixed with Bradford reagent, and protein concentration determined by measuring absorbance at 590 nm (20) . All results were expressed as femtomoles cyclic nucleotide per microgram total cell protein. As a positive control for cGMP, RMIC were exposed to 10 nM ANF for 10 min.
Determination of nitrite levels. RMIC in 24-well plates were exposed to 0.1-100 nM ET-1 in KRB at 370C for 5-30 min. After incubation, duplicate 50-Ml aliquots of the supernatants were removed and immediately tested for nitrite (NO-) levels (stable breakdown product of nitric oxide) as previously described (21) . To each aliquot, 100 ILI of Greiss reagent (1% sulfanilamide in 30% acetic acid and 0.1% N-(l-naphthyl)ethylenediamine dihydrochloride in 60% acetic acid in a 1:1 mixture) was added and mixed for one min. Absorbance at 550 nm was immediately measured in a microplate reader (Thermomax; Molecular Devices Corp., Menlo Park, CA). NO-levels were determined by comparing sample values with a standard curve established with known quantities of sodium nitrite. The cells were solubilized with 0.1 N NaOH and total protein determined as described above.
Statistics. All results are compared by ANOVA. P < 0.05 was deemed significant as determined by the Scheffe F-test. All data are expressed as mean±SEM.
Results
RMIC contraction. Incubation of RMIC in KRB alone for up to 60 min had no significant effect on cell surface area. ET-1 (10 nM) caused a slowly developing reduction in surface area that was maximal (75.3±1.9% of original cell surface area) 30 min after addition of the peptide (Fig. 1 B) . The response to ET-1 was dose-dependent with a significant, albeit small, contraction occurring at 10 pM ET-1 (Fig. 1 A) . Cells were stained for F-actin filaments (with rhodamine-phalloidin) after a 30-min incubation in KRB alone or containing 10 nM ET-1. As is apparent from Fig. 3 , ET-1 caused a marked increase in the number and the intensity of F-actin filaments in RMIC, providing further support for ET-1 -stimulated contractile activity by RMIC.
AVP (10 nM) also contracted RMIC (Fig. 2) . The response to AVP was maximal by 15 min and persisted for at least 1 h. This was faster than the contraction observed with ET-1; the reasons for the different response times is uncertain, but could reflect differences in ligand stimulation of factors modifying RMIC contraction such as PGE2 (see below). Similar to ET-1, AVP caused a marked increase in the number and intensity of F-actin microfilaments (Fig. 3) .
Mechanism ofET-l -induced RMIC contraction. To explore the mechanism(s) of ET-1-stimulated RMIC contraction, the effect of a variety of agents on the ET-1 response was examined. As shown in Fig. 4 , nifedipine, an inhibitor of voltage-sensitive calcium channels, did not significantly alter ET-l-induced contraction. In contrast, nickel, an inorganic blocker of calcium channels, reduced, but did not completely inhibit, the contractile response to ET-1. Neither nickel nor nifedipine, when given alone, had an effect on RMIC surface area. H7, a protein kinase C inhibitor, had no effect on unstimulated RMIC surface area, but completely blocked the contractile response to ET-1. Hence, ET-1 stimulated RMIC contraction is dependent in part on voltage-insensitive extracellular calcium entry -and is mediated through activation of protein kinase C. ET-1 stimulates RMIC production of PGE2 (13, 22) , an eicosanoid which can inhibit the vasoconstrictive effect of ET-1 (23). To determine if cyclooxygenase products modify the contractile response to ET-1 in RMIC, cells were treated with indomethacin followed by addition of ET-1 (Fig. 5) . Indomethacin alone cause a slight, but significant, increase in RMIC surface area, suggesting that basal cyclooxygenase products may tonically contract these cells. In contrast, indomethacin potentiated the contractile effect of ET-1, suggesting that ET-1 stimulation of a cyclooxygenase product decreases the contractile response to the peptide. The effect of PGE2 on the ET-1-induced contraction in the presence of indomethacin was examined since this is the major eicosanoid produced by RMIC. As shown in Fig. 5 , PGE2 markedly reduced the contractile response to ET-1, supporting an inhibitory role for the prostanoid. Nitric oxide (NO) is a well known antagonist of ET-1, inhibiting both ET-1 production (24) and smooth muscle contraction (25) . To examine whether NO could be modifying the ET-1 response, RMIC were preincubated with NMMA, an antagonist of NO action. The dose of NMMA used has been previously shown to completely block endogenous NO production by a number of cell types (21) . NMMA had no effect on basal RMIC surface area nor did it alter ET-1 -induced contraction (Fig. 4) , suggesting that NO is not involved in mediating the'ET-1 response. Nitrite levels were examined in supernatants of cells incubated with media alone or containing 10 nM ET-1 for up to 30 min, however no nitrite was detected under any conditions. This assay is relatively insensitive since the Greiss reagent detects only microgram quantities of nitrite and could, therefore, have missed less dramatic alterations in endogenous NO production. To further examine an alteration in endogenous NO levels, the effect of ET-1 on cGMP (the mediator of NO actions) accumulation in RMIC was also quantitated. ET-1 did cause a very modest reduction in cGMP levels, but only at relatively high concentrations (10-100 nM) of the peptide (Fig.  6 B) . The cGMP system was clearly responsive in these cells as ANF markedly increased cGMP levels. These data suggest, that a small reduction in NO might play a relatively minor role in mediating ET-l -induced RMIC contraction, but is unlikely to be of physiologic significance.
Since alterations in cAMP accumulation have been implicated in cell contraction, the effect of ET-1 on RMIC cAMP levels was examined. ET-1, at doses which clearly elicited contraction, had no effect on RMIC cAMP accumulation (Fig. 6  A) , indicating that this is not the mechanism by which ET-1 -induced RMIC contraction occurs.
Discussion
The current study demonstrates that RMIC are contractile cells. ET-1 and AVP cause a long-lasting reduction in RMIC surface area that is associated with marked increases in the number and intensity of F-actin microfilament staining. The in culture tend to lose their contractility. Although it is not possible to draw conclusions about the physiologic relevance of RMIC contraction from the current study, one must consider how the contractile state of these cells could potentially impact on medullary function. RMIC are intimately associated with loops of Henle and blood vessels and, to a lesser extent, with medullary collecting ducts (2) . Consequently, RMIC form a bridge predominantly between Henle's loops and blood vessels that are oriented with the long axis of the RMIC perpendicular to the long axis of the papilla (6). This results in a ladder-like structure in which RMIC could limit axial diffusion (6) . How then could RMIC contraction modify renal medullary function? First, RMIC contraction may reduce medullary interstitial volume by pulling Henle's loops, blood vessels, and to a lesser extent collecting ducts, closer to one another. This would result in less distance for water and solutes to diffuse, facilitating exchange between the tubules and the blood. Whether this mechanism could be physiologically important is, however, uncertain. Wexler and colleagues have proposed a model to explain medullary urine concentration that assumes a significant physical separation between the collecting duct and Henle's limbs (26). In contrast, anatomical studies have demonstrated a relatively small distance between collecting ducts and Henle's limbs (27) , raising doubts as to the role of distance between these tubule segments in modulating urine concentration. This issue remains unresolved, however, since RMIC contraction during the process of tissue fixation could alter medullary geometry. Further, the architecture of the renal medulla is notoriously difficult to preserve during fixation due to the high tonicity (2) . A second possibility is that a reduction in papillary volume were preincubated with INDO for 30 min, followed by addition of ET-l and/or PGE2 for 30 min. Cell area was determined in these latter studies immediately before and 30 min after addition of ET-1 and/or PGE2. n = 3-6 each data point. * P < 0.001 vs control; * * P < 0.025 vs control; # P < 0.001 vs INDO alone or vs control and P < 0.01 vs ET-l alone; f P < 0.005 vs control, ET-l alone, and INDO + ET-1.
role of RMIC contraction can be tested, however, the current finding that RMIC do indeed contract should provide impetus to the development of relevant techniques.
ET-1 has been demonstrated to bind to RMIC and elicit increases in the concentration of cytosolic-free Ca2 , inositol trisphosphate, and PGE2 (13, 22, 28 ). In the current study ET-1 was shown to contract RMIC at a concentration as low as 10 pM and half-maximal contraction at -100 pM. This concentration range for ET-1 action is somewhat lower than that described by Wilkes and coworkers for the initial rise in cytosolic Ca2+ concentration and inositol trisphosphate levels in RMIC (0.5 and 1 nM ET-1, respectively) (13). This group did note, however, that a second sustained rise in cytosolic-free Ca2+ concentration in RMIC was associated with activation of receptoroperated calcium channels and occurred at ET-1 concentrations as low as 1 fm. Our finding that nickel, but not nifedipine, inhibits ET-1-induced contraction lends further support to the notion that ET-1 activates dihydropyridine-insensitive, receptoroperated calcium channels in RMIC.
The current study explored several potential mechanisms for ET-1-induced RMIC contraction. ET-1-induced RMIC contraction is dependent upon activation of protein kinase C since H7 completely blocks the ET-1 effect. This finding is in agreement with previous data showing that protein kinase C is an important mediator of at least some aspects of ET-1 -induced signal transduction in RMIC (activation of phospholipase D) (28) . ET-1 did not alter cAMP levels and only modestly reduced cGMP levels at concentrations of ET-1 that were well above those required to elicit RMIC contraction. Nitric oxide does not appear to mediate the ET-1 response in these cells since NMMA had no effect on RMIC contraction after simulation with ET-1. Perhaps of greatest interest was the finding that indomethacin potentiates ET-1 action, while addition of PGE2 reduces ET-1-elicited RMIC contraction. Taken together with previous studies showing that stimulates PGE2 production by RMIC ( 13, 22) , these data indicate that PGE2 is a negative modulator of ET-l -stimulated RMIC contraction. That ET-1 regulates RMIC contraction suggests an interesting and complex system of ET-1 action in the inner medulla. ET-1 is not produced by RMIC (13); rather, it derives from adjacent inner medullary collecting duct (IMCD) ( 14) and possibly endothelial cells (29) . In the IMCD, ET-1 inhibits vasopressin-stimulated water (30, 31) , and possibly sodium (32), reabsorption. In contrast, we speculate that ET-1, by contracting RMIC, would enhance water reabsorption. RMIC express only ETA receptors (13) , while ET-1 exerts its effects on IMCD cells through activation of ETB receptors (33) . Hence, the net effect of ET-1 action in the inner medulla may depend upon the relative degree of activation of the two endothelin receptor subtypes. It should also be noted that these considerations do not take into account ET-1 actions on vasa recta and medullary blood flow.
AVP also contracts RMIC in culture. This demonstrates that RMIC contraction is not unique to ET-1. In addition, it raises the interesting possibility that RMIC contraction might contribute to AVP-mediated increases in urine concentration. Detailed studies on the mechanism of AVP-stimulated RMIC contraction of ET-1 are clearly needed.
In summary, the current study demonstrates that RMIC are contractile cells. ET-1 elicits RMIC contraction through activation of protein kinase C and receptor-operated calcium channels. AVP also contracts RMIC; the mechanism of this effect requires further investigation. In addition, it will be of great interest to determine the effect of other agents that bind to RMIC, including angiotensin II and ANF, on RMIC contraction. Further, a role for PGE2 in modifying the effects of these agents on RMIC contraction merits examination. Finally, studies are needed which are designed to investigate the role of RMIC contraction in regulating renal medullary function.
